| RS2476113679 |
MTTP
|
Health Risk |
Likely pathogenic |
— |
| RS2476118093 |
MTTP
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2476118133 |
MTTP
|
Health Risk |
Likely pathogenic |
Abetalipoproteinaemia, Abetalipoproteinaemia |
| RS2476118381 |
MTTP
|
Health Risk |
Pathogenic |
— |
| RS2476124246 |
MTTP
|
Health Risk |
Likely pathogenic |
Abetalipoproteinaemia, Abetalipoproteinaemia |
| RS2476124425 |
MTTP
|
Health Risk |
Likely pathogenic |
Abetalipoproteinaemia, Abetalipoproteinaemia |
| RS2476126262 |
MTTP
|
Health Risk |
Likely pathogenic |
Abetalipoproteinaemia, Abetalipoproteinaemia |
| RS2476126352 |
MTTP
|
Health Risk |
Pathogenic |
— |
| RS2476134780 |
MTTP
|
Health Risk |
Likely pathogenic |
Abetalipoproteinaemia, Abetalipoproteinaemia |
| RS2476134985 |
MTTP
|
Health Risk |
Pathogenic |
— |
| RS2476136524 |
ANTXR2
|
Health Risk |
Likely pathogenic |
Hyaline fibromatosis syndrome, Hyaline fibromatosis syndrome |
| RS2476136571 |
ANTXR2
|
Health Risk |
Likely pathogenic |
Hyaline fibromatosis syndrome, Hyaline fibromatosis syndrome |
| RS2476136983 |
COL4A4
|
Health Risk |
Likely pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS2476138261 |
COL4A4
|
Health Risk |
Likely pathogenic |
COL4A4-related disorder, COL4A4-related disorder |
| RS2476139225 |
ANTXR2
|
Health Risk |
Likely pathogenic |
Hyaline fibromatosis syndrome, Hyaline fibromatosis syndrome |
| RS2476140169 |
COL4A4
|
Health Risk |
Likely pathogenic |
— |
| RS2476140446 |
ALB
|
Health Risk |
Pathogenic |
— |
| RS2476141279 |
MTTP
|
Health Risk |
Likely pathogenic |
Abetalipoproteinaemia, Abetalipoproteinaemia |
| RS2476141442 |
MTTP
|
Health Risk |
Likely pathogenic |
Abetalipoproteinaemia, Abetalipoproteinaemia |
| RS2476141537 |
MTTP
|
Health Risk |
Likely pathogenic |
MTTP-related disorder, MTTP-related disorder |
| RS2476141732 |
MTTP
|
Health Risk |
Likely pathogenic |
Abetalipoproteinaemia, Abetalipoproteinaemia |
| RS2476145104 |
MTTP
|
Health Risk |
Pathogenic |
— |
| RS2476145662 |
MTTP
|
Health Risk |
Likely pathogenic |
— |
| RS2476145822 |
MTTP
|
Health Risk |
Pathogenic |
— |
| RS2476145911 |
MTTP
|
Health Risk |
Pathogenic |
— |
| RS2476145943 |
MTTP
|
Health Risk |
Likely pathogenic |
Abetalipoproteinaemia, Abetalipoproteinaemia |
| RS2476146041 |
MTTP
|
Health Risk |
Likely pathogenic |
Abetalipoproteinaemia, Abetalipoproteinaemia |
| RS2476146079 |
MTTP
|
Health Risk |
Likely pathogenic |
Abetalipoproteinaemia, Abetalipoproteinaemia |
| RS2476149064 |
MTTP
|
Health Risk |
Likely pathogenic |
Abetalipoproteinaemia, Abetalipoproteinaemia |
| RS2476149238 |
MTTP
|
Health Risk |
Likely pathogenic |
Abetalipoproteinaemia, Abetalipoproteinaemia |
| RS2476149269 |
MTTP
|
Health Risk |
Likely pathogenic |
Abetalipoproteinaemia, Abetalipoproteinaemia |
| RS2476149431 |
MTTP
|
Health Risk |
Likely pathogenic |
Abetalipoproteinaemia, Abetalipoproteinaemia |
| RS2476157027 |
NFKB1
|
Health Risk |
Likely pathogenic |
— |
| RS2476158124 |
MTTP
|
Health Risk |
Pathogenic/Likely pathogenic |
Abetalipoproteinaemia, Abetalipoproteinaemia |
| RS2476158333 |
MTTP
|
Health Risk |
Likely pathogenic |
Abetalipoproteinaemia, Abetalipoproteinaemia |
| RS2476161572 |
MTTP
|
Health Risk |
Likely pathogenic |
— |
| RS2476161600 |
MTTP
|
Health Risk |
Pathogenic |
— |
| RS2476178924 |
NFKB1
|
Health Risk |
Likely pathogenic |
NFKB1-related disorder, NFKB1-related disorder |
| RS2476179011 |
AIMP1
|
Health Risk |
Pathogenic |
— |
| RS2476179074 |
AIMP1
|
Health Risk |
Pathogenic |
— |
| RS2476199260 |
AIMP1
|
Health Risk |
Pathogenic |
— |
| RS2476200380 |
NFKB1
|
Health Risk |
Pathogenic |
— |
| RS2476200825 |
NFKB1
|
Health Risk |
Likely pathogenic |
— |
| RS2476203152 |
PPP3CA
|
Health Risk |
Likely pathogenic |
PPP3CA-related disorder, PPP3CA-related disorder |
| RS2476203153 |
PPP3CA
|
Health Risk |
Pathogenic |
— |
| RS2476210016 |
PPP3CA
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 91, Developmental and epileptic encephalopathy 91 |
| RS2476210177 |
PPP3CA
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 91, Developmental and epileptic encephalopathy 91 |
| RS2476210936 |
SCARB2
|
Health Risk |
Pathogenic |
Progressive myoclonic epilepsy, Progressive myoclonic epilepsy |
| RS2476210999 |
SCARB2
|
Health Risk |
Likely pathogenic |
Progressive myoclonic epilepsy, Progressive myoclonic epilepsy |
| RS2476213850 |
GABRA2
|
Health Risk |
Likely pathogenic |
— |
| RS2476220505 |
MTRR
|
Health Risk |
Likely pathogenic |
Neural tube defects, folate-sensitive |
| RS2476228193 |
SCARB2
|
Health Risk |
Likely pathogenic |
Progressive myoclonic epilepsy, Progressive myoclonic epilepsy |
| RS2476228297 |
SCARB2
|
Health Risk |
Pathogenic |
Progressive myoclonic epilepsy, Progressive myoclonic epilepsy |
| RS2476235922 |
COL4A4
|
Health Risk |
Likely pathogenic |
Autosomal recessive Alport syndrome, Hematuria |
| RS2476237771 |
COL4A4
|
Health Risk |
Pathogenic |
— |
| RS2476238585 |
COL4A4
|
Health Risk |
Pathogenic/Likely pathogenic |
Alport syndrome, Hematuria |
| RS2476240165 |
COL4A4
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2476241131 |
COL4A4
|
Health Risk |
Pathogenic |
— |
| RS2476242345 |
COL4A4
|
Health Risk |
Likely pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS2476245865 |
COL4A4
|
Health Risk |
Likely pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS2476284377 |
SCARB2
|
Health Risk |
Pathogenic |
Progressive myoclonic epilepsy, Progressive myoclonic epilepsy |
| RS2476297677 |
PPP3CA
|
Health Risk |
Pathogenic |
— |
| RS2476318271 |
SCARB2
|
Health Risk |
Pathogenic/Likely pathogenic |
Progressive myoclonic epilepsy, Action myoclonus-renal failure syndrome |
| RS2476334676 |
ACADVL
|
Health Risk |
Likely pathogenic |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS2476350193 |
NFKB1
|
Health Risk |
Likely pathogenic |
NFKB1-related disorder, NFKB1-related disorder |
| RS2476350261 |
NFKB1
|
Health Risk |
Pathogenic |
— |
| RS2476350553 |
NFKB1
|
Health Risk |
Pathogenic |
— |
| RS2476351116 |
NFKB1
|
Health Risk |
Pathogenic |
— |
| RS2476351129 |
NFKB1
|
Health Risk |
Pathogenic |
— |
| RS2476351160 |
NFKB1
|
Health Risk |
Pathogenic |
— |
| RS2476357331 |
PKD2
|
Health Risk |
Pathogenic |
Polycystic kidney disease 2, Polycystic kidney disease 2 |
| RS2476357504 |
PKD2
|
Health Risk |
Pathogenic |
PKD2-related disorder, PKD2-related disorder |
| RS2476357618 |
PKD2
|
Health Risk |
Pathogenic |
Autosomal dominant polycystic kidney disease, Autosomal dominant polycystic kidney disease |
| RS2476357791 |
PKD2
|
Health Risk |
Pathogenic |
Polycystic kidney disease 2, Polycystic kidney disease 2 |
| RS2476357829 |
PKD2
|
Health Risk |
Pathogenic |
Polycystic kidney disease 2, Polycystic kidney disease 2 |
| RS2476357872 |
PKD2
|
Health Risk |
Pathogenic |
Polycystic kidney disease 2, Polycystic kidney disease 2 |
| RS2476357922 |
PKD2
|
Health Risk |
Pathogenic |
Polycystic kidney disease 2, Polycystic kidney disease 2 |
| RS2476358222 |
PKD2
|
Health Risk |
Pathogenic |
Polycystic kidney disease 2, Polycystic kidney disease 2 |
| RS2476358273 |
PKD2
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2476358625 |
PKD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Autosomal dominant polycystic kidney disease |
| RS2476358800 |
PKD2
|
Health Risk |
Pathogenic |
Polycystic kidney disease 2, Polycystic kidney disease 2 |
| RS2476402911 |
NFKB1
|
Health Risk |
Pathogenic |
— |
| RS2476404144 |
NFKB1
|
Health Risk |
Pathogenic |
— |
| RS2476410487 |
NDUFAF5
|
Health Risk |
Pathogenic |
— |
| RS2476415372 |
NFKB1
|
Health Risk |
Pathogenic |
— |
| RS2476415934 |
NFKB1
|
Health Risk |
Pathogenic |
— |
| RS2476416063 |
NFKB1
|
Health Risk |
Likely pathogenic |
— |
| RS2476425600 |
NFKB1
|
Health Risk |
Pathogenic |
— |
| RS2476435464 |
NFKB1
|
Health Risk |
Likely pathogenic |
— |
| RS2476435904 |
NFKB1
|
Health Risk |
Pathogenic |
— |
| RS2476436133 |
NFKB1
|
Health Risk |
Likely pathogenic |
Immunodeficiency, common variable |
| RS2476439283 |
NDNF
|
Health Risk |
Likely pathogenic |
Hypogonadotropic hypogonadism 25 with anosmia, Hypogonadotropic hypogonadism 25 with anosmia |
| RS2476445162 |
BBS7
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2476446609 |
BBS7
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 7, Bardet-Biedl syndrome 7 |
| RS2476446836 |
NFKB1
|
Health Risk |
Likely pathogenic |
— |
| RS2476446922 |
NFKB1
|
Health Risk |
Likely pathogenic |
NFKB1-related disorder, NFKB1-related disorder |
| RS2476455936 |
BBS7
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2476456020 |
BBS7
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 7, Bardet-Biedl syndrome 7 |
| RS2476456347 |
BBS7
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2476456461 |
BBS7
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome 7, Bardet-Biedl syndrome 7 |